CCL2 and metabolic dysfunction-associated steatohepatitis: In murine models of NASH, hepato-vagotomy worsens hepatic inflammation by upregulating tumor necrosis factor alpha (TNFα), interleukin 12 (IL-12), and monocyte chemoattractant protein 1 (MCP-1).